Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2026
Patient sues Eli Lilly over stomach problems tied to Mounjaro and Trulicity
Lawsuit filed
A patient has filed a lawsuit against Eli Lilly, alleging stomach problems that the patient ties to the medications Mounjaro and Trulicity, as reported by The Indiana Lawyer. The event was reported on October 8, 2026. The lawsuit concerns the patient's claim of stomach problems associated with the two medications. No further details regarding the outcome or additional allegations are provided in the source.
Stated objective. To stop the sale of counterfeit retatrutide
Company response
Denial — Eli Lilly
In an emailed statement, a spokesperson for Eli Lilly called the complaint “baseless”
Denial — CVS
Spokespersons for CVS and Novo Nordisk said they intend to “vigorously defend” against the claims in the lawsuit.
Denial — Novo Nordisk
Spokespersons for CVS and Novo Nordisk said they intend to “vigorously defend” against the claims in the lawsuit.
Denial — Sanofi
Sanofi said its pricing practices have “always complied with the law.”
Source excerpt
Eli Lilly sued over stomach problems patient ties to Mounjaro and Trulicity
Caleb Amick, The Indiana Lawyer
On Aug. 12, Eli Lilly announced it had filed six lawsuits against companies that it claims are illegally selling retatrutide.
2026
Former Eli Lilly representative sues over alleged Mounjaro marketing
Lawsuit filed
Former Eli Lilly sales representative Jennifer Mansion sued the company, alleging retaliation after she objected to Lilly's alleged promotion of Mounjaro for weight loss, a use described in the complaint as not approved at the time. The retaliation charge remains an allegation, not an established court finding.
Source excerpt
An alleged Mounjaro marketing dispute is at the center of former Eli Lilly and Co. sales representative Jennifer Mansion's lawsuit, which accuses the company of retaliation after she objected.
Mansion's complaint dates the end of her employment to Nov. 9, 2023. It says she had objected to Lilly's alleged promotion of Mounjaro for weight loss.
The complaint describes weight loss as a use that had not been approved at the time. The retaliation charge remains Mansion's allegation and is not an established court finding.